MYO Assay (MYO Assay ) - India CDSCO Medical Device Registration

MYO Assay (MYO Assay ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_f5ad648d570ca79ed18c13ae701e751a_da437ab5a03f614b32f9906afc75a9b5. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

MYO Assay (MYO Assay )

UID: IMP/IVD/2023/000207_f5ad648d570ca79ed18c13ae701e751a_da437ab5a03f614b32f9906afc75a9b5

Brand Name

CLIA

License Holder

Rapid House

Device Class

Class B

Approving Authority

CDSCO

Product Information

MYO Assay (CLIA) is for the in vitro quantitative determination of Myoglobin (CLIA) in human serum and plasma.,β-HCG Assay (CLIA)(β-HCG Assay (CLIA))-β-HCG Assay (CLIA) is for the in vitro quantitative determination of -Human Chorionic Gonadotropin (CLIA) in human serum and plasma